maklogo
Market Research Report

Global Cryogenic Capsules Market Insights, Size, and Forecast By Application (Medical, Cryogenic Storage, Space Exploration, Industrial Processes), By Capacity (Small Capacity, Medium Capacity, Large Capacity, Custom Capacity), By Material Type (Stainless Steel, Aluminum, Composite Materials, Glass), By End Use Industry (Healthcare, Aerospace, Food & Beverage, Energy), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:99164
Published Date:Jan 2026
No. of Pages:215
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Cryogenic Capsules Market is projected to grow from USD 2.85 Billion in 2025 to USD 5.42 Billion by 2035, reflecting a compound annual growth rate of 8.7% from 2026 through 2035. The cryogenic capsules market encompasses specialized containers designed for the ultra-low temperature storage and transportation of various sensitive biological materials, chemicals, and gases. These capsules are critical for preserving the viability and integrity of contents such as vaccines, blood samples, stem cells, and high-purity gases, extending their shelf life and ensuring their efficacy. Key market drivers include the burgeoning biopharmaceutical industry, with increasing demand for cell and gene therapies, personalized medicine, and robust cold chain logistics. Advancements in cryopreservation techniques, coupled with rising investments in healthcare infrastructure and research and development activities across both developed and emerging economies, are further propelling market expansion. The Medical segment currently holds the largest market share, underscoring the critical role of cryogenic capsules in healthcare applications ranging from diagnostics to therapeutic development. Innovation in material science, leading to the development of more durable and efficient insulation materials, is a significant trend, alongside the growing adoption of smart cryogenic solutions incorporating real-time monitoring capabilities.

Global Cryogenic Capsules Market Value (USD Billion) Analysis, 2025-2035

maklogo
8.7%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

Despite robust growth, the market faces certain restraints, including the high initial cost associated with cryogenic equipment and infrastructure, as well as the stringent regulatory landscape governing the storage and transport of sensitive biological materials. Technical challenges related to maintaining ultra-low temperatures consistently over extended periods and ensuring capsule integrity during transport also pose hurdles. However, significant opportunities abound. The expansion of biobanking initiatives globally, the increasing prevalence of chronic diseases necessitating advanced medical treatments, and the growing demand for assisted reproductive technologies are creating new avenues for market players. Furthermore, the rise of industrial applications requiring cryogenic storage, such as in superconductor technology and advanced manufacturing, presents diversification opportunities. North America currently dominates the market, primarily due to the presence of a well-established healthcare and biotechnology sector, significant R&D investments, and robust regulatory frameworks supporting advanced medical practices.

The Asia Pacific region is anticipated to be the fastest growing market, driven by rapidly developing healthcare infrastructure, increasing government support for life science research, and a growing patient pool seeking advanced medical treatments. Economic growth and rising disposable incomes in countries like China and India are also fostering greater investment in healthcare and biotechnology. Key players in this competitive landscape include Universal Boson, MVE Biological Solutions, Advanced Cryogenics, North Star Ice Equipment, Hampshire Chemical, Cryofab, Praxair, Vacuum Barrier Corporation, Air Products, and Cryo Innovations. These companies are employing strategies such as product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market position and expand their global footprint. Focusing on developing energy-efficient and technologically advanced capsules, improving supply chain efficiency, and catering to the diverse needs of end-use industries across Applications, Material Type, Capacity, and End Use Industry segments are crucial for sustained success in this evolving market.

Quick Stats

  • Market Size (2025):

    USD 2.85 Billion

  • Projected Market Size (2035):

    USD 5.42 Billion

  • Leading Segment:

    Medical (42.8% Share)

  • Dominant Region (2025):

    North America (38.2% Share)

  • CAGR (2026-2035):

    8.7%

Global Cryogenic Capsules Market Emerging Trends and Insights

CryoCapsule Remote Monitoring Evolution

The CryoCapsule Remote Monitoring Evolution signifies a major shift in the global cryogenic capsules market, driven by enhanced safety and operational efficiency. Originally, monitoring was largely manual and required frequent onsite checks for parameters like temperature and pressure within storage vessels. This presented challenges, particularly for geographically dispersed or hazardous locations. The trend now emphasizes sophisticated remote systems utilizing sensors and networked communication. This evolution allows real time data transmission to central command centers, enabling continuous oversight of capsule conditions without physical proximity. Operators can proactively identify deviations, predict maintenance needs, and respond rapidly to potential issues, minimizing human error and risk. This transformation improves sample integrity, reduces operational costs, and expands the usability of cryogenic capsules in diverse and demanding environments, from scientific research to healthcare.

Sustainable Cryogenic Storage Innovations

The global cryogenic capsules market is experiencing a significant shift towards sustainable storage innovations. This trend is driven by a growing demand for environmentally friendly solutions and reduced operational costs. Manufacturers are developing capsules with improved insulation properties utilizing advanced materials like vacuum insulated panels and high performance composites to minimize heat leak and prolong storage duration. Emphasis is placed on recyclable and reusable components as well as materials with lower embodied energy. Technologies like passive cooling systems and phase change materials are being integrated to further enhance energy efficiency and reduce reliance on active cooling. The aim is to create cryogenic storage solutions that are not only effective and reliable but also minimize their environmental footprint throughout their lifecycle.

Personalized Biobanking Solutions Rise

Personalized biobanking solutions are gaining prominence in the global cryogenic capsules market as researchers and healthcare providers seek tailored preservation strategies. Historically, biobanks operated on a more standardized, bulk collection model. The shift reflects a growing demand for bespoke solutions that cater to individual donor profiles, specific sample types, and unique research objectives. This trend is driven by advancements in precision medicine and cellular therapies, where the integrity and specific characteristics of individual biological samples are paramount. Companies are now offering customized capsule designs, specialized preservation media, and bespoke storage protocols to optimize viability and utility for each donor. This ensures higher quality samples for future research, diagnostics, and therapeutic applications, moving beyond a one size fits all approach.

What are the Key Drivers Shaping the Global Cryogenic Capsules Market

Rising Demand from Healthcare & Life Sciences for Cryopreservation

The healthcare and life sciences sectors are experiencing a significant surge in demand for cryopreservation, directly fueling the cryogenic capsules market. This upward trend is driven by several key factors. Advances in regenerative medicine, cell therapies, and organ transplantation necessitate the long term, viable storage of biological materials like stem cells, tissues, and reproductive cells. Research institutions and pharmaceutical companies are increasingly employing cryopreservation for drug discovery, toxicology studies, and maintaining vast biobanks of samples for future analysis. Furthermore, the growing global population and increased life expectancy contribute to a higher incidence of age related diseases, prompting greater investment in therapies reliant on cryogenically stored biological assets. The need for precise, contamination free, and highly secure storage solutions for these invaluable materials makes cryogenic capsules indispensable, thus propelling their market growth.

Expanding Applications in Industrial Gas and Energy Sectors

The increasing adoption of cryogenic capsules stems from their vital role in supporting the expansion of industrial gas and energy sectors. As these industries broaden their scope and production capabilities, the demand for efficient and safe storage and transport solutions for cryogenic gases escalates. This includes applications in liquefied natural gas production and distribution, industrial gas manufacturing for various processes, and the emerging hydrogen economy. Cryogenic capsules are indispensable for handling extremely low temperature materials like liquid oxygen, nitrogen, argon, and methane, which are crucial for energy generation, chemical processing, and scientific research. Their secure containment and controlled dispensing capabilities enable these sectors to scale operations, develop new applications, and meet growing global energy and industrial demands, thereby driving market growth.

Technological Advancements in Cryogenic Storage and Transportation

Technological advancements in cryogenic storage and transportation are a significant driver for the global cryogenic capsules market. Innovations continually improve the efficiency and safety of storing and moving cryogenic materials at ultra low temperatures. Enhanced insulation materials minimize heat leakage preserving sample integrity and reducing operational costs. Advanced sensor technologies provide real time monitoring of temperature pressure and liquid levels ensuring optimal conditions and preventing material degradation. Developments in vacuum technology further improve thermal performance and reduce boil off rates. Lighter stronger and more durable materials for capsule construction also contribute to easier handling and increased lifespan. These advancements expand the range of applications for cryogenic capsules making them more reliable accessible and cost effective across various industries from healthcare and biotechnology to aerospace and energy.

Global Cryogenic Capsules Market Restraints

Stringent Regulatory Approval Processes for New Cryogenic Capsule Designs

Stringent regulatory approval processes for new cryogenic capsule designs represent a significant hurdle for manufacturers. Developing innovative capsules for long term storage of biological materials requires extensive testing to ensure safety, efficacy, and material integrity under extreme low temperatures. Companies must navigate complex and often lengthy certification procedures mandated by various national and international health organizations. This involves demonstrating compliance with rigorous standards for biocompatibility, structural stability, thermal performance, and containment capabilities. The high cost and time investment associated with these approvals can delay market entry for novel designs, stifle innovation, and limit the introduction of advanced technologies. Manufacturers face increased research and development expenses and prolonged product development cycles, impacting their ability to respond quickly to evolving market needs and potentially hindering their competitive advantage.

High Initial Capital Investment and Operating Costs for Cryogenic Infrastructure

Developing the necessary cryogenic infrastructure demands substantial upfront financial commitment. Establishing liquefaction plants, storage facilities, and specialized transportation networks requires significant investment in advanced machinery, specialized materials, and skilled labor. These high initial capital outlays can be a formidable barrier for new entrants and even established players considering expansion. Furthermore, maintaining these complex systems incurs substantial ongoing operational costs. Energy consumption for cooling and liquefaction is considerable, alongside regular maintenance, safety inspections, and the specialized workforce needed to manage cryogenic processes. These high ongoing expenses contribute to the overall economic burden, potentially limiting the widespread adoption and expansion of cryogenic capsule solutions, particularly in regions with less developed industrial infrastructure or those with limited access to substantial capital for such specialized projects.

Global Cryogenic Capsules Market Opportunities

Cryogenic Capsule Innovations for Advanced Cell & Gene Therapy and Personalized Medicine Logistics

The burgeoning fields of advanced cell and gene therapy alongside personalized medicine present a compelling opportunity for innovation within cryogenic capsules. These transformative treatments, often custom tailored for individual patients, critically depend on ultra reliable, secure, and precise cold chain logistics. Maintaining the viability and integrity of fragile biological materials, from collection to administration, necessitates more sophisticated cryogenic storage solutions than traditionally available.

This opportunity focuses on developing next generation capsules featuring enhanced thermal stability, improved traceability mechanisms, and designs optimized for diverse, high value cellular products and biomaterials. Innovations include smart monitoring integration, advanced materials resisting physical stress, and miniaturized formats facilitating efficient transport within complex global supply chains. Such advancements are crucial for the safe, effective, and scalable delivery of these life saving therapies, driving demand particularly in fast growing healthcare markets like Asia Pacific where adoption is accelerating. These innovations will revolutionize personalized medicine logistics by ensuring sample integrity and patient safety.

Smart Cryogenic Capsules for Enhanced Cold Chain Integrity in Global Biologics & Vaccine Distribution

The surging global demand for biologics and vaccines intensifies the need for unwavering cold chain integrity. Traditional cryogenic transport methods often lack real-time visibility, risking temperature excursions and compromising product efficacy, especially across complex international routes. This critical vulnerability creates a significant market opportunity for smart cryogenic capsules.

These advanced capsules integrate sophisticated sensors and data logging capabilities, providing continuous, verifiable monitoring of vital parameters like temperature and pressure throughout transit. This intelligent oversight ensures superior cold chain integrity, safeguarding the potency and viability of high-value biopharmaceuticals from production to patient. Such innovation drastically reduces waste, enhances regulatory compliance, and builds profound trust in essential medical supply chains. The opportunity lies in deploying these reliable, verifiable ultra-low temperature solutions globally, meeting the stringent demands of vaccine and biologic distribution, particularly in rapidly expanding markets.

Global Cryogenic Capsules Market Segmentation Analysis

Key Market Segments

By Application

  • •Medical
  • •Cryogenic Storage
  • •Space Exploration
  • •Industrial Processes

By Material Type

  • •Stainless Steel
  • •Aluminum
  • •Composite Materials
  • •Glass

By Capacity

  • •Small Capacity
  • •Medium Capacity
  • •Large Capacity
  • •Custom Capacity

By End Use Industry

  • •Healthcare
  • •Aerospace
  • •Food & Beverage
  • •Energy

Segment Share By Application

Share, By Application, 2025 (%)

  • Medical
  • Cryogenic Storage
  • Industrial Processes
  • Space Exploration
maklogo
$2.85BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is the Medical application segment dominating the Global Cryogenic Capsules Market?

The Medical application segment holds a significant share primarily due to the critical demand for biological sample preservation, cell therapy, and in vitro fertilization. This directly translates to substantial adoption within the Healthcare end use industry. The stringent requirements for maintaining ultra low temperatures to preserve delicate samples like vaccines, blood components, and genetic material drive consistent and high volume demand, positioning medical use as the market's primary growth driver.

How do Material Type and Capacity segments cater to the varied demands across industries?

Material type segmentation highlights choices based on durability, thermal efficiency, and cost effectiveness. Stainless steel offers robust solutions for critical long term storage, while aluminum provides lighter alternatives suitable for specific applications. Capacity segmentation, ranging from small to large and custom, ensures that diverse needs from individual laboratory samples to industrial scale storage are met, allowing for optimized solutions across the entire end use spectrum.

Beyond healthcare, what role do other application and end use industry segments play in market diversification?

Cryogenic storage, space exploration, and industrial processes diversify the market significantly. Space exploration, for instance, requires specialized composite materials for extreme conditions and custom capacities for propellant or scientific payloads. The Energy sector, alongside food and beverage, also utilizes cryogenic capsules for gas storage and transportation, showcasing the broad applicability of these advanced containment solutions across a multitude of high tech and industrial end use industries.

Global Cryogenic Capsules Market Regulatory and Policy Environment Analysis

The Global Cryogenic Capsules Market operates within a complex and evolving regulatory landscape driven by safety, quality, and international trade considerations. Stringent manufacturing standards, often aligning with ISO certifications and Good Manufacturing Practices GMP, are paramount across regions to ensure product integrity and prevent contamination of sensitive contents. Regulations governing the storage and transportation of cryogenic materials, including hazardous goods classifications, impact logistics and supply chains, with adherence to International Air Transport Association IATA and International Maritime Organization IMO guidelines being crucial.

Furthermore, national health authorities like the US FDA, European Medicines Agency EMA, and similar bodies worldwide impose specific requirements, particularly when capsules are used for medical or pharmaceutical applications. This includes medical device classification, product registration, and rigorous quality control protocols. Labeling, traceability, and batch control are essential for accountability and recalls. Environmental regulations also influence manufacturing processes and disposal. Data privacy laws, such as GDPR, indirectly affect associated service providers storing biological samples, impacting industry practices. Harmonization efforts aim to standardize these diverse global requirements.

Which Emerging Technologies Are Driving New Trends in the Market?

The Global Cryogenic Capsules Market is experiencing transformative innovations. Advanced material science is driving the development of lighter, stronger composites with superior thermal insulation properties, significantly extending sample viability and reducing liquid nitrogen consumption. This enhances energy efficiency and lowers operational costs for biobanks and research facilities. Emerging technologies focus on smart capsules featuring integrated sensors for real time temperature, pressure, and fill level monitoring, ensuring optimal storage conditions. RFID and blockchain technology are increasingly adopted for secure, precise tracking and immutable provenance of valuable biological samples. Automation in filling, sealing, and retrieval systems is improving throughput and minimizing human error. Further advancements include novel cryoprotectant delivery systems and improved biocompatible materials, ensuring the integrity and long term viability of sensitive biomaterials. These innovations are critical for personalized medicine, gene therapy, and regenerative medicine advancements.

Global Cryogenic Capsules Market Regional Analysis

Global Cryogenic Capsules Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 38.2% share

North America dominates the Global Cryogenic Capsules Market with a substantial 38.2% market share. This strong position is primarily driven by the region's advanced healthcare infrastructure and significant investment in biotechnology and pharmaceutical research. The presence of leading medical device manufacturers and a robust regulatory framework that supports innovation further solidifies North America's leadership. High adoption rates of cutting edge medical technologies for biobanking and regenerative medicine also contribute to this regional dominance. Expanding research and development activities particularly in cell and gene therapies requiring precise cryogenic storage are expected to maintain North America's prominent role in the coming years. The demand for reliable and efficient cryogenic storage solutions in both clinical and research settings remains consistently high across the United States and Canada.

Fastest Growing Region

Asia Pacific · 11.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global cryogenic capsules market, projected to expand at an impressive CAGR of 11.2% from 2026 to 2035. This remarkable growth is fueled by several key factors. Rapid advancements in healthcare infrastructure across emerging economies like India and China are significantly boosting demand for cryogenic solutions in biobanking and assisted reproductive technologies. The increasing prevalence of chronic diseases and genetic disorders further necessitates the storage of biological samples, driving the adoption of cryogenic capsules. Moreover, a burgeoning pharmaceutical and biotechnology sector in the region is investing heavily in research and development, creating a sustained need for reliable cryopreservation tools. Finally, government initiatives promoting healthcare access and the rising awareness about regenerative medicine are contributing to this accelerated market expansion.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical dynamics influencing the cryogenic capsules market include increasing space exploration endeavors, particularly from nations like China, India, and the UAE, driving demand for launch vehicle components. Geopolitical stability is crucial for supply chain resilience, as manufacturing often spans multiple countries. Trade policies and tariffs, especially between major technological blocs, can impact material costs and access to advanced manufacturing equipment essential for high-performance capsules. Furthermore, international collaborations on large-scale scientific projects, such as fusion energy research, directly stimulate demand for specialized cryogenic containment solutions, making multilateral agreements key.

Macroeconomic factors center on global economic growth and investment in science and technology. Robust economic growth generally translates to higher government and private sector spending on space, healthcare, and industrial gas applications, all significant consumers of cryogenic capsules. Inflationary pressures on raw materials like aluminum and composites, coupled with energy costs for manufacturing and transportation, can affect profitability. Interest rate policies impact the cost of capital for expanding production capabilities or funding research initiatives requiring advanced cryogenic systems. Global health crises can also shift demand towards specialized medical cryogenic storage, impacting market dynamics.

Recent Developments

  • March 2025

    Universal Boson launched a new line of advanced cryogenic capsules featuring integrated IoT sensors for real-time monitoring of temperature and pressure. This innovation aims to enhance the safety and traceability of valuable biological samples during long-term storage and transport.

  • January 2025

    MVE Biological Solutions announced a strategic partnership with a leading pharmaceutical logistics provider to expand its cryogenic capsule distribution network across emerging markets. This collaboration focuses on improving cold chain infrastructure to support the growing demand for gene therapies and personalized medicine.

  • November 2024

    Cryofab completed the acquisition of a specialized vacuum insulation technology company, strengthening its R&D capabilities for ultra-low temperature storage solutions. This acquisition is expected to lead to the development of more efficient and durable cryogenic capsules with extended holding times.

  • September 2024

    Advanced Cryogenics introduced a new eco-friendly cryogenic capsule made from recyclable composite materials, reducing the environmental impact of their products. This initiative aligns with growing industry trends towards sustainability and responsible manufacturing practices in the cryogenic sector.

Key Players Analysis

Key players like Universal Boson and MVE Biological Solutions drive the Global Cryogenic Capsules Market, leveraging advanced vacuum insulation and material science. Companies such as Advanced Cryogenics and Cryofab specialize in custom designs and manufacturing. Praxair and Air Products, major industrial gas suppliers, integrate capsule production into broader cryogenic solutions. Strategic initiatives include expanding into healthcare and aerospace, with market growth propelled by rising demand for cryopreservation and LNG transportation.

List of Key Companies:

  1. Universal Boson
  2. MVE Biological Solutions
  3. Advanced Cryogenics
  4. North Star Ice Equipment
  5. Hampshire Chemical
  6. Cryofab
  7. Praxair
  8. Vacuum Barrier Corporation
  9. Air Products
  10. Cryo Innovations
  11. Cryogenetic Systems
  12. Linde
  13. Chart Industries
  14. Cryoport
  15. Greenfield Technologies

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 2.85 Billion
Forecast Value (2035)USD 5.42 Billion
CAGR (2026-2035)8.7%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Application:
    • •Medical
    • •Cryogenic Storage
    • •Space Exploration
    • •Industrial Processes
  • By Material Type:
    • •Stainless Steel
    • •Aluminum
    • •Composite Materials
    • •Glass
  • By Capacity:
    • •Small Capacity
    • •Medium Capacity
    • •Large Capacity
    • •Custom Capacity
  • By End Use Industry:
    • •Healthcare
    • •Aerospace
    • •Food & Beverage
    • •Energy
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.1.1. Medical
5.1.2. Cryogenic Storage
5.1.3. Space Exploration
5.1.4. Industrial Processes
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
5.2.1. Stainless Steel
5.2.2. Aluminum
5.2.3. Composite Materials
5.2.4. Glass
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
5.3.1. Small Capacity
5.3.2. Medium Capacity
5.3.3. Large Capacity
5.3.4. Custom Capacity
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
5.4.1. Healthcare
5.4.2. Aerospace
5.4.3. Food & Beverage
5.4.4. Energy
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.1.1. Medical
6.1.2. Cryogenic Storage
6.1.3. Space Exploration
6.1.4. Industrial Processes
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
6.2.1. Stainless Steel
6.2.2. Aluminum
6.2.3. Composite Materials
6.2.4. Glass
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
6.3.1. Small Capacity
6.3.2. Medium Capacity
6.3.3. Large Capacity
6.3.4. Custom Capacity
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
6.4.1. Healthcare
6.4.2. Aerospace
6.4.3. Food & Beverage
6.4.4. Energy
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.1.1. Medical
7.1.2. Cryogenic Storage
7.1.3. Space Exploration
7.1.4. Industrial Processes
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
7.2.1. Stainless Steel
7.2.2. Aluminum
7.2.3. Composite Materials
7.2.4. Glass
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
7.3.1. Small Capacity
7.3.2. Medium Capacity
7.3.3. Large Capacity
7.3.4. Custom Capacity
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
7.4.1. Healthcare
7.4.2. Aerospace
7.4.3. Food & Beverage
7.4.4. Energy
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.1.1. Medical
8.1.2. Cryogenic Storage
8.1.3. Space Exploration
8.1.4. Industrial Processes
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
8.2.1. Stainless Steel
8.2.2. Aluminum
8.2.3. Composite Materials
8.2.4. Glass
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
8.3.1. Small Capacity
8.3.2. Medium Capacity
8.3.3. Large Capacity
8.3.4. Custom Capacity
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
8.4.1. Healthcare
8.4.2. Aerospace
8.4.3. Food & Beverage
8.4.4. Energy
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.1.1. Medical
9.1.2. Cryogenic Storage
9.1.3. Space Exploration
9.1.4. Industrial Processes
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
9.2.1. Stainless Steel
9.2.2. Aluminum
9.2.3. Composite Materials
9.2.4. Glass
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
9.3.1. Small Capacity
9.3.2. Medium Capacity
9.3.3. Large Capacity
9.3.4. Custom Capacity
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
9.4.1. Healthcare
9.4.2. Aerospace
9.4.3. Food & Beverage
9.4.4. Energy
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Cryogenic Capsules Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.1.1. Medical
10.1.2. Cryogenic Storage
10.1.3. Space Exploration
10.1.4. Industrial Processes
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
10.2.1. Stainless Steel
10.2.2. Aluminum
10.2.3. Composite Materials
10.2.4. Glass
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Capacity
10.3.1. Small Capacity
10.3.2. Medium Capacity
10.3.3. Large Capacity
10.3.4. Custom Capacity
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use Industry
10.4.1. Healthcare
10.4.2. Aerospace
10.4.3. Food & Beverage
10.4.4. Energy
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Universal Boson
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. MVE Biological Solutions
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Advanced Cryogenics
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. North Star Ice Equipment
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Hampshire Chemical
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Cryofab
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Praxair
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Vacuum Barrier Corporation
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Air Products
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Cryo Innovations
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Cryogenetic Systems
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Linde
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Chart Industries
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Cryoport
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Greenfield Technologies
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 2: Global Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 3: Global Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 4: Global Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 5: Global Cryogenic Capsules Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 7: North America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 8: North America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 9: North America Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 10: North America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 12: Europe Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 13: Europe Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 14: Europe Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 15: Europe Cryogenic Capsules Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 17: Asia Pacific Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 18: Asia Pacific Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 19: Asia Pacific Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 20: Asia Pacific Cryogenic Capsules Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 22: Latin America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 23: Latin America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 24: Latin America Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 25: Latin America Cryogenic Capsules Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Cryogenic Capsules Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 27: Middle East & Africa Cryogenic Capsules Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 28: Middle East & Africa Cryogenic Capsules Market Revenue (USD billion) Forecast, by Capacity, 2020-2035

Table 29: Middle East & Africa Cryogenic Capsules Market Revenue (USD billion) Forecast, by End Use Industry, 2020-2035

Table 30: Middle East & Africa Cryogenic Capsules Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Packaging Transport Market Research

Explore comprehensive market research reports covering all aspects of the Packaging Transport industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;